Cargando…
BRAF mutation testing with a rapid, fully integrated molecular diagnostics system
Fast and accurate diagnostic systems are needed for further implementation of precision therapy of BRAF-mutant and other cancers. The novel Idylla(TM) BRAF Mutation Test has high sensitivity and shorter turnaround times compared to other methods. We used Idylla to detect BRAF V600 mutations in archi...
Autores principales: | Janku, Filip, Claes, Bart, Huang, Helen J., Falchook, Gerald S., Devogelaere, Benoit, Kockx, Mark, Bempt, Isabelle Vanden, Reijans, Martin, Naing, Aung, Fu, Siqing, Piha-Paul, Sarina A., Hong, David S., Holley, Veronica R., Tsimberidou, Apostolia M., Stepanek, Vanda M., Patel, Sapna P., Kopetz, E. Scott, Subbiah, Vivek, Wheler, Jennifer J., Zinner, Ralph G., Karp, Daniel D., Luthra, Rajyalakshmi, Roy-Chowdhuri, Sinchita, Sablon, Erwin, Meric-Bernstam, Funda, Maertens, Geert, Kurzrock, Razelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694960/ https://www.ncbi.nlm.nih.gov/pubmed/26330075 |
Ejemplares similares
-
PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes
por: Janku, Filip, et al.
Publicado: (2012) -
Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancer
por: Falchook, Gerald S., et al.
Publicado: (2014) -
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
por: Janku, Filip, et al.
Publicado: (2015) -
Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
por: Janku, Filip, et al.
Publicado: (2015) -
Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway
por: Wheler, Jennifer J., et al.
Publicado: (2014)